Dr. Machtay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
500 University Drive
Hershey, PA 17033Phone+1 717-531-4477- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemResidency, Radiation Oncology, 1990 - 1993
- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1989 - 1990
- New York University School of MedicineClass of 1989
Certifications & Licensure
- PA State Medical License 1991 - 2024
- OH State Medical License 2009 - 2024
- NJ State Medical License 1993 - 2011
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Philadelphia Magazine Castle Connolly, 2005-2006, 2009-2010
Clinical Trials
- Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer Start of enrollment: 1998 Dec 01
- Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer Start of enrollment: 2000 Jun 01
- Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-I...Andrew J Gross, Saad Sheikh, Michael Kharouta, Kevin Chaung, Serah Choi, Seunghee Margevicius, Pingfu Fu, Mitchell Machtay, Debora S Bruno, Afshin Dowlati, Tithi Biswas> ;Clinical Lung Cancer. 2023 Dec 1
- 3 citationsSafety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Founda...Maura L Gillison, Robert L Ferris, Jonathan Harris, A Dimitrios Colevas, Loren K Mell, Christina Kong, Richard C Jordan, Kevin L Moore, Minh-Tam Truong, Claudia Kirsch...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Mar 15
- 6 citationsLow-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, Igor J Barani, Steve Braunstein, Joseph A Bovi, Jo...> ;Neuro-Oncology. 2023 Jan 5
- Join now to see all
Journal Articles
- Multi-Institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients with Brain MetastasesSimon S Lo, Wenyin Shi, Kristin J Redmond, Mitchell Machtay, JAMA Oncology
Other
- Treatment of early (stage I and II) head and neck cancer: The larynxMachtay M, Koch WM
http://www.uptodate.com/contents/treatment-of-early-stage-i-and-ii-head-and-neck-cancer-the-larynx
UpToDate, Wolters Kluwer Health - 2013-02-05
Press Mentions
- Machtay Named Cancer Institute Associate Director for Clinical ResearchSeptember 29th, 2020
- How the COVID-19 Pandemic Has Affected Cancer Care, ResearchMay 13th, 2020
- Case Comprehensive Cancer Center Awarded $8.9 Million to Expand Access to Clinical TrialsMay 16th, 2019
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- American Society of Radiation OncologyFellow
Hospital Affiliations
- Penn State Milton S. Hershey Medical CenterHershey, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: